口腔医学研究 ›› 2025, Vol. 41 ›› Issue (9): 781-787.DOI: 10.13701/j.cnki.kqyxyj.2025.09.008

• 牙周病学研究 • 上一篇    下一篇

百里香酚通过调控炎症通路抑制脂多糖诱导的大鼠牙龈成纤维细胞炎症的研究

郭嘉1, 高梦洁1, 牛慧1, 刘丹枫2, 陈曦1*   

  1. 1.郑州大学第一附属医院郑东院区口腔内科 郑州 河南 450052;
    2.郑州大学第一附属医院牙体牙髓科 郑州 河南 450052
  • 收稿日期:2025-02-13 出版日期:2025-09-28 发布日期:2025-09-24
  • 通讯作者: * 陈曦,E-mail:2423074549@qq.com
  • 作者简介:郭嘉(1983~ ),男,河南焦作人,博士,副主任医师,研究方向:牙周病学及口腔遗传病学。
  • 基金资助:
    河南省医学科技攻关计划联合共建项目基金(2023年度)(编号:LHGJ20230242)

Thymol Inhibits LPS-induced Inflammation in Rat Gingival Fibroblasts by Regulating Inflammatory Pathways

GUO Jia1, GAO Mengjie1, NIU Hui1, LIU Danfeng2, CHEN Xi1*   

  1. 1. Department of Stomatology, Zhengdong Branch of the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China;
    2. Department of Endodontics and Endodontics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
  • Received:2025-02-13 Online:2025-09-28 Published:2025-09-24

摘要: 目的: 探讨百里香酚(Thymol)对牙龈卟啉单胞菌(Porphyromonas gingivalis,P. g)的影响,和对脂多糖(lipopolysaccharide,LPS)诱导的大鼠牙龈成纤维细胞炎症反应的抑制作用。方法: 采用微量稀释法测定Thymol对P. g的最低抑菌浓度(minimum inhibitory concentration,MIC)和杀菌浓度(minimum bactericidal concentration,MBC);生物膜粘附减少-结晶紫法测定Thymol对P. g的抗生物膜活性;扫描电子显微镜和共聚焦激光扫描显微镜(confocal scanning laser microscopy,CSLM)检测细菌。通过大鼠牙龈成纤维细胞建立5组牙周炎体外实验模型:对照组、LPS+不同浓度Thymol(0、10、20、40 μg/mL)组。通过ELISA测定上清中相关蛋白的表达,包括肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)、白细胞介素-1β(interleukin-1β,IL-1β)、白细胞介素-6(interleukin-6,IL-6)、白细胞介素-10(interleukin-10,IL-10)、骨保护素(osteoclastogenesis inhibitory factor,OPG)和核因子kappa-B配体的可溶性受体激活因子(soluble receptor activator of nuclear factor-κB ligand,sRANKL),并计算OPG/sRANKL比值;采用Western blot检测牙龈成纤维细胞核蛋白中NF-κB p65和IκBα的磷酸化水平。结果: Thymol减弱了P. g的毒性和生物膜形成。与LPS组相比,Thymol刺激后,细胞上清液中炎症因子TNF-α、IL-1β和IL-6的表达水平显著降低,而抗炎因子IL-10的表达水平显著升高;OPG/sRANKL比值增加;LPS诱导的NF-κB p65和IκBα的磷酸化水平显著降低(P<0.001)。结论: Thymol通过抑制P. g的毒性和生物膜形成,调控相关炎症因子的表达(TNF-α、IL-1β、IL-6、IL-10、OPG/sRANKL)及炎症通路(NF-κB p65、IκBα),抑制LPS诱导的大鼠牙龈成纤维细胞的炎症反应。

关键词: 百里香酚, 牙龈卟啉单胞菌, 脂多糖, 牙龈成纤维细胞, NF-κB 通路

Abstract: Objective: To investigate the effect of thymol on Porphyromonas gingivalis (P. g) and lipopolysaccharide (LPS)-induced inflammatory response in rat gingival fibroblasts. Methods: The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of thymol against P. g were determined by microdilution method. Biofilm adhesion reduction-crystal violet assay was used to determine the anti-biofilm activity of thymol against P. g. Bacteria were detected by scanning electron microscopy and confocal scanning laser microscopy (CSLM). Rat gingival fibroblasts were used to establish periodontitis models in vitro: control group, LPS + different concentrations of thymol (0, 10, 20, and 40 μg/mL) groups. ELISA was used to measure the expression of related proteins in the supernatant, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), osteoclastogenesis inhibitory factor (OPG) and soluble receptor activator of nuclear factor-κB ligand (sRANKL), and OPG/sRANKL ratio was calculated. Western blot was used to detect the phosphorylation of NF-κB p65 and IκBα in the nuclear protein of gingival fibroblasts. Results: Thymol attenuated P. g toxicity and biofilm formation. Thymol had no adverse effect on LPS-induced growth of rat gingival fibroblasts. Compared with LPS group, the expression levels of inflammatory factors TNF-α, IL-1β, and IL-6 in the cell supernatant were significantly decreased after Thymol stimulation, while the expression level of anti-inflammatory factor IL-10 was significantly increased. The ratio of OPG/sRANKL was increased. LPS-induced phosphorylation of NF-κB p65 and IκBα was significantly decreased(P<0.001). Conclusion: Thymol inhibits P. g toxicity and biofilm formation, and inhibits LPS-induced inflammation in GFS by regulating the expression of related inflammatory factors (TNF-α, IL-1β, IL-6, IL-10, OPG/sRANKL) and inflammatory pathways (NF-κB p65, IκBα).

Key words: thymol, Porphyromonas gingivalis, lipopolysaccharide, gingival fibroblasts, NF-κB signaling pathway